Oregon Drug Discovery Symposium at KCRB 4
Hundreds listen in at the Oregon Drug Discovery Symposium at Oregon Health & Science University’s Knight Cancer Research Building. (OHSU/Christine Torres Hicks)
Oregon Drug Discovery Symposium at KCRB 3
Brian Druker, M.D., and Shereef Elnahal, M.D., M.B.A., speak with Sanjay Malthotra, Ph.D., at the Oregon Drug Discovery Symposium at Oregon Health & Science University’s Knight Cancer Research Building. (OHSU/Christine Torres Hicks)
Oregon Drug Discovery Symposium 1
Oregon Gov. Tina Kotek speaks at the Oregon Drug Discovery Symposium at Oregon Health & Science University’s Knight Cancer Research Building. (OHSU/Christine Torres Hicks)
Knight Lifetime Achievement Award
Brian Druker, M.D., receives the inaugural Knight Lifetime Achievement Award, presented by OHSU President Shereef Elnahal, M.D., M.B.A. The award is named for Nike founder Phil Knight, a longtime supporter of the OHSU Knight Cancer Institute. (OHSU/Erik Robinson)
Oregon Drug Discovery Symposium 2
Brian Druker, M.D., Shereef Elnahal, M.D., M.B.A., Oregon Gov. Tina Kotek, and Sanjay Malhotra, Ph.D., FRSC, at the OHSU Knight Cancer Institute. (OHSU/Christine Torres Hicks)
Druker gana la primera instancia del premio Knight Lifetime Achievement
Brian Druker, M.D., Shereef Elnahal, M.D., M.B.A., la gobernadora de Oregón Tina Kotek y Sanjay Malhotra, Ph.D., FRSC, en el OHSU Knight Cancer Institute. (OHSU/Christine Torres Hicks)
Druker gana la primera instancia del premio Knight Lifetime Achievement
Cientas de personas escuchan el Oregon Drug Discovery Symposium en el edificio del Knight Cancer Research en Oregon Health & Science University. (OHSU/Christine Torres Hicks)
Investigación de OHSU revela cómo el cáncer de páncreas bloquea la inmunoterapia
OHSU research reveals how pancreatic cancer blocks immunotherapy